Identification of tumor-specific Salmonella Typhimurium promoters and their regulatory logic

scientific article

Identification of tumor-specific Salmonella Typhimurium promoters and their regulatory logic is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/NAR/GKR1041
P932PMC publication ID3326293
P698PubMed publication ID22140114
P5875ResearchGate publication ID51852241

P2093author name stringDirk Bumann
Helmut Bloecker
Holger Loessner
Igor V Deyneko
Kathrin Wolf
Sara Leschner
Siegfried Weiss
Stefan Lienenklaus
P2860cites workEcoCyc: a comprehensive database of Escherichia coli biologyQ24612081
Quantifying similarity between motifsQ27499384
Fitting a mixture model by expectation maximization to discover motifs in biopolymersQ27860556
WebLogo: A Sequence Logo GeneratorQ27860646
Examination of Salmonella gene expression in an infected mammalian host using the green fluorescent protein and two-colour flow cytometryQ30828698
Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanomaQ33340438
Salmonella promoters preferentially activated inside tumorsQ33344346
Tumor invasion of Salmonella enterica serovar Typhimurium is accompanied by strong hemorrhage promoted by TNF-alphaQ33495169
Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimuriumQ33756746
Vessel destruction by tumor-targeting Salmonella typhimurium A1-R is enhanced by high tumor vascularityQ34620886
Drug resistance and cellular adaptation to tumor acidic pH microenvironmentQ35592647
Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancerQ35840470
The use of clostridial spores for cancer treatment.Q36565145
Host-microbe communication within the GI tract.Q37289355
Salmonella-allies in the fight against cancerQ37762990
Modulation of natural immunity in the gut by Escherichia coli strain Nissle 1917.Q37774424
Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccinesQ39513114
Remote control of tumour-targeted Salmonella enterica serovar Typhimurium by the use of L-arabinose as inducer of bacterial gene expression in vivoQ40171422
Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to dogs with spontaneous neoplasia: phase I evaluationQ40504400
Continuous intravenous administration of live genetically modified salmonella typhimurium in patients with metastatic melanomaQ43161957
Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude miceQ43677697
Biofilm formation by Salmonella enterica serovar Typhimurium colonizing solid tumoursQ50042401
From spinach scare to cancer careQ50043261
Containment of tumor-colonizing bacteria by host neutrophilsQ50062621
Identification of host-induced pathogen genes by differential fluorescence induction reporter systemsQ50072446
Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumorsQ50102730
Tumor-targeted Salmonella as a novel anticancer vectorQ50133173
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectSalmonella TyphimuriumQ166491
P304page(s)2984-2994
P577publication date2011-12-02
P1433published inNucleic Acids ResearchQ135122
P1476titleIdentification of tumor-specific Salmonella Typhimurium promoters and their regulatory logic
P478volume40

Reverse relations

cites work (P2860)
Q34315760A bioluminescent transposon reporter-trap identifies tumor-specific microenvironment-induced promoters in Salmonella for conditional bacterial-based tumor therapy
Q64124307Advances in bacterial cancer therapies using synthetic biology
Q34381649An integrative computational approach to effectively guide experimental identification of regulatory elements in promoters
Q26751222Bacteria in Cancer Therapy: Renaissance of an Old Concept
Q37718566Bacterial Carriers for Glioblastoma Therapy
Q90716178Bacterial delivery of the anti-tumor azurin-like protein Laz to glioblastoma cells
Q37231785Candidate SNP Markers of Chronopathologies Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene Promoters.
Q36760451Candidate SNP Markers of Gender-Biased Autoimmune Complications of Monogenic Diseases Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene Promoters
Q36255004Candidate SNP markers of aggressiveness-related complications and comorbidities of genetic diseases are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters.
Q54936700Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters.
Q36015577Composing a Tumor Specific Bacterial Promoter
Q90777022Genetic circuit design automation for the gut resident species Bacteroides thetaiotaomicron
Q96126440Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity
Q40163572Local application of bacteria improves safety of Salmonella -mediated tumor therapy and retains advantages of systemic infection.
Q38203911Murine solid tumours as a novel model to study bacterial biofilm formation in vivo
Q64241311Natural Selection Equally Supports the Human Tendencies in Subordination and Domination: A Genome-Wide Study With Confirmation and Validation in Mice
Q35875387Obesity-related known and candidate SNP markers can significantly change affinity of TATA-binding protein for human gene promoters
Q38391065Phenotypic evolution of therapeutic Salmonella enterica serovar Typhimurium after invasion of TRAMP mouse prostate tumor
Q26996526Salmonella enterica serovars Typhimurium and Typhi as model organisms: revealing paradigm of host-pathogen interactions
Q39339432Salmonella-Mediated Cancer Therapy: Roles and Potential
Q37225613Therapy of solid tumors using probiotic Symbioflor-2: restraints and potential
Q58599910Tumour-targeting bacteria engineered to fight cancer

Search more.